| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.4M | — |
| R&D Expense | $86.8M | -44.0% |
| SG&A Expense | $42.1M | -29.8% |
| Operating Income | -$126.4M | +41.2% |
| Net Income | -$123.3M | +42.4% |
| EPS (Basic) | -$18.69 | -302.8% |
| EPS (Diluted) | -$18.69 | -302.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $81.3M | +31.9% |
| Current Assets | $84.9M | -23.4% |
| Total Assets | $87.9M | -23.6% |
| Current Liabilities | $15.7M | -54.1% |
| Total Liabilities | $18.3M | -53.2% |
| Stockholders' Equity | $69.7M | -8.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$111.1M | +39.9% |
| Capital Expenditures | $50K | -88.7% |
| Investing Cash Flow | $39.0M | -59.8% |
| Financing Cash Flow | $91.9M | +777.9% |
| Free Cash Flow | -$111.2M | +40.1% |